A Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002)

Clinical trial NCT04934670 · TERMINATED

Trial details

NCT number: NCT04934670
Sponsor: Xenikos
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Steroid-Refractory Acute Graft Versus Host Disease

Start date: 2022-06-16
Primary completion: 2022-11-10
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.